Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02922920 · ClinicalTrials.gov registry record · NA
Effects of Tart Cherry Juice on the Body
A NA study of Age-related Cognitive Decline and Cardiovascular Risk Factors, sponsored by University of Delaware.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT02922920: Completed NA study of Age-related Cognitive Decline and Cardiovascular Risk Factors, sponsored by University of Delaware.
NCT02922920 is a NA study of Age-related Cognitive Decline and Cardiovascular Risk Factors that has completed, run by University of Delaware. The registered enrollment target is 37 participants, below the 1,130-participant average among 10 other Age-related Cognitive Decline trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02922920, a NA study of Age-related Cognitive Decline and Cardiovascular Risk Factors, has completed, sponsored by University of Delaware.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
Tart cherries are a rich source of antioxidants. Studies have shown that tart cherries exert anti-oxidative and anti-inflammatory properties. The purpose of this study is to learn about the effects of drinking tart cherry juice on cardiovascular and cognitive health.
Primary Outcome
Change from baseline in cognitive test performance at 12 weeks
Conditions Studied
Interventions
- OTHER Placebo
- OTHER Tart cherry juice
Study Locations (1)
Delaware
- University of Delaware - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2014-11 |
| Est. Completion | 2016-09 |
| Phase | NA |
What the finished NCT02922920 record still lists
NCT02922920 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 1,130-participant average among 10 other Age-related Cognitive Decline trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Age-related Cognitive Decline appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02922920 reports a single indexed study location in Delaware.
Frequently Asked Questions
What is clinical trial NCT02922920 about?
NCT02922920 is a clinical study titled "Effects of Tart Cherry Juice on the Body". Tart cherries are a rich source of antioxidants. Studies have shown that tart cherries exert anti-oxidative and anti-inflammatory properties. The purpose of this study is to learn about the effects of drinking tart cherry juice on cardiovascular and cognitive health.
What is the current status of trial NCT02922920?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2014-11. Estimated completion is 2016-09.
What conditions does trial NCT02922920 study?
This clinical trial studies the following conditions: Age-related Cognitive Decline, Cardiovascular Risk Factors.
What interventions are being tested in trial NCT02922920?
The interventions under investigation include: Placebo (OTHER), Tart cherry juice (OTHER).
Who is sponsoring clinical trial NCT02922920?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02922920 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Cognitive Decline
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02922920's enrollment target sits among peer trials
37 9th of 10 higher than 2 of 10 other Age-related Cognitive Decline trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Age-related Cognitive Decline trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment
RECRUITING · NA
-
The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia
RECRUITING · NA
-
Cardiac-Control Affecting Learning Through Mindfulness (CALM)
RECRUITING · NA
-
Brain Enhancement Training Towards Elders Resilience to Aging, Phase IIB
COMPLETED · NA
-
Cognitive Multi-Tasking Training in Healthy Older Adults
COMPLETED · NA
-
Attention Training for Learning Enhancement and Resilience Trial
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia